Differences in the reduced18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: Correlations with the three main symptoms

Makoto Otsuka, Yuichi Ichiya, Yasuo Kuwabara, Shinichi Hosokawa, Masayuki Sasaki, Tsuyoshi Yoshida, Toshimitsu Fukumura, Kouji Masuda, Motohiro Kalo

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

It has been reported that the F-Dopa (FD) uptake in patients with idiopathic Parkinson's disease (PD) decreased significantly in the caudate and putamen when compared to controls. The FD uptake severely decreased in the putamen, while it was relatively spared in the caudate nucleus. We also previously reported that atypical parkinsonism with no or little tremor showed a homogeneously reduced FD uptake in both the caudate and the putamen. In this study we evaluated the caudate and the putaminal FD uptakes in relation to the three main symptoms in PD. The FD uptake was measured by PET with 6-L-[18F]fluorodopa in 17 patients with PD. The caudate and the putaminal FD uptake ratios to the cerebellum at 120 min were evaluated. The caudate and the putaminal FD uptake ratios in the patients with PD decreased as their clinical stages advanced. These decreases also correlated with the degree of rigidity and bradykinesia. However, such decreases did not correlate with the degree of tremor. The caudate-putamen index (CPIX%), which was calculated by a formula based on the difference in the uptakes of the caudate and putamen divided by the caudate uptake, indicated 11.6±3.6, 16.5±5.5 and 18.3±4.1 in the group of no, mild and moderate tremor, respectively, and increased as the degree of tremor advanced. The CPI in the group of moderate tremor significantly increased from that in the group of no tremor (P<0.04). However, the CPI did not correlate with the clinical stage, the degree of rigidity or the degree of bradykinesia. The FD/PET study therefore effectively demonstrated the severity of the clinical symptoms of rigidity and bradykinesia in patients with PD in correlation with a decrease in the FD uptakes in the caudate and the putamen, and it also demonstrated that the severity of tremor might have a different mechanism from that of such other symptoms as rigidity and bradykinesia.

Original languageEnglish
Pages (from-to)169-173
Number of pages5
JournalJournal of the Neurological Sciences
Volume136
Issue number1-2
DOIs
Publication statusPublished - Jan 1 1996

Fingerprint

Dihydroxyphenylalanine
Putamen
Parkinson Disease
Tremor
Hypokinesia
Caudate Nucleus
Parkinsonian Disorders
Cerebellum

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology

Cite this

Differences in the reduced18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease : Correlations with the three main symptoms. / Otsuka, Makoto; Ichiya, Yuichi; Kuwabara, Yasuo; Hosokawa, Shinichi; Sasaki, Masayuki; Yoshida, Tsuyoshi; Fukumura, Toshimitsu; Masuda, Kouji; Kalo, Motohiro.

In: Journal of the Neurological Sciences, Vol. 136, No. 1-2, 01.01.1996, p. 169-173.

Research output: Contribution to journalArticle

Otsuka, Makoto ; Ichiya, Yuichi ; Kuwabara, Yasuo ; Hosokawa, Shinichi ; Sasaki, Masayuki ; Yoshida, Tsuyoshi ; Fukumura, Toshimitsu ; Masuda, Kouji ; Kalo, Motohiro. / Differences in the reduced18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease : Correlations with the three main symptoms. In: Journal of the Neurological Sciences. 1996 ; Vol. 136, No. 1-2. pp. 169-173.
@article{eb37e5b7827845dfbcec4df35df0d61e,
title = "Differences in the reduced18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: Correlations with the three main symptoms",
abstract = "It has been reported that the F-Dopa (FD) uptake in patients with idiopathic Parkinson's disease (PD) decreased significantly in the caudate and putamen when compared to controls. The FD uptake severely decreased in the putamen, while it was relatively spared in the caudate nucleus. We also previously reported that atypical parkinsonism with no or little tremor showed a homogeneously reduced FD uptake in both the caudate and the putamen. In this study we evaluated the caudate and the putaminal FD uptakes in relation to the three main symptoms in PD. The FD uptake was measured by PET with 6-L-[18F]fluorodopa in 17 patients with PD. The caudate and the putaminal FD uptake ratios to the cerebellum at 120 min were evaluated. The caudate and the putaminal FD uptake ratios in the patients with PD decreased as their clinical stages advanced. These decreases also correlated with the degree of rigidity and bradykinesia. However, such decreases did not correlate with the degree of tremor. The caudate-putamen index (CPIX{\%}), which was calculated by a formula based on the difference in the uptakes of the caudate and putamen divided by the caudate uptake, indicated 11.6±3.6, 16.5±5.5 and 18.3±4.1 in the group of no, mild and moderate tremor, respectively, and increased as the degree of tremor advanced. The CPI in the group of moderate tremor significantly increased from that in the group of no tremor (P<0.04). However, the CPI did not correlate with the clinical stage, the degree of rigidity or the degree of bradykinesia. The FD/PET study therefore effectively demonstrated the severity of the clinical symptoms of rigidity and bradykinesia in patients with PD in correlation with a decrease in the FD uptakes in the caudate and the putamen, and it also demonstrated that the severity of tremor might have a different mechanism from that of such other symptoms as rigidity and bradykinesia.",
author = "Makoto Otsuka and Yuichi Ichiya and Yasuo Kuwabara and Shinichi Hosokawa and Masayuki Sasaki and Tsuyoshi Yoshida and Toshimitsu Fukumura and Kouji Masuda and Motohiro Kalo",
year = "1996",
month = "1",
day = "1",
doi = "10.1016/0022-510X(95)00316-T",
language = "English",
volume = "136",
pages = "169--173",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Differences in the reduced18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease

T2 - Correlations with the three main symptoms

AU - Otsuka, Makoto

AU - Ichiya, Yuichi

AU - Kuwabara, Yasuo

AU - Hosokawa, Shinichi

AU - Sasaki, Masayuki

AU - Yoshida, Tsuyoshi

AU - Fukumura, Toshimitsu

AU - Masuda, Kouji

AU - Kalo, Motohiro

PY - 1996/1/1

Y1 - 1996/1/1

N2 - It has been reported that the F-Dopa (FD) uptake in patients with idiopathic Parkinson's disease (PD) decreased significantly in the caudate and putamen when compared to controls. The FD uptake severely decreased in the putamen, while it was relatively spared in the caudate nucleus. We also previously reported that atypical parkinsonism with no or little tremor showed a homogeneously reduced FD uptake in both the caudate and the putamen. In this study we evaluated the caudate and the putaminal FD uptakes in relation to the three main symptoms in PD. The FD uptake was measured by PET with 6-L-[18F]fluorodopa in 17 patients with PD. The caudate and the putaminal FD uptake ratios to the cerebellum at 120 min were evaluated. The caudate and the putaminal FD uptake ratios in the patients with PD decreased as their clinical stages advanced. These decreases also correlated with the degree of rigidity and bradykinesia. However, such decreases did not correlate with the degree of tremor. The caudate-putamen index (CPIX%), which was calculated by a formula based on the difference in the uptakes of the caudate and putamen divided by the caudate uptake, indicated 11.6±3.6, 16.5±5.5 and 18.3±4.1 in the group of no, mild and moderate tremor, respectively, and increased as the degree of tremor advanced. The CPI in the group of moderate tremor significantly increased from that in the group of no tremor (P<0.04). However, the CPI did not correlate with the clinical stage, the degree of rigidity or the degree of bradykinesia. The FD/PET study therefore effectively demonstrated the severity of the clinical symptoms of rigidity and bradykinesia in patients with PD in correlation with a decrease in the FD uptakes in the caudate and the putamen, and it also demonstrated that the severity of tremor might have a different mechanism from that of such other symptoms as rigidity and bradykinesia.

AB - It has been reported that the F-Dopa (FD) uptake in patients with idiopathic Parkinson's disease (PD) decreased significantly in the caudate and putamen when compared to controls. The FD uptake severely decreased in the putamen, while it was relatively spared in the caudate nucleus. We also previously reported that atypical parkinsonism with no or little tremor showed a homogeneously reduced FD uptake in both the caudate and the putamen. In this study we evaluated the caudate and the putaminal FD uptakes in relation to the three main symptoms in PD. The FD uptake was measured by PET with 6-L-[18F]fluorodopa in 17 patients with PD. The caudate and the putaminal FD uptake ratios to the cerebellum at 120 min were evaluated. The caudate and the putaminal FD uptake ratios in the patients with PD decreased as their clinical stages advanced. These decreases also correlated with the degree of rigidity and bradykinesia. However, such decreases did not correlate with the degree of tremor. The caudate-putamen index (CPIX%), which was calculated by a formula based on the difference in the uptakes of the caudate and putamen divided by the caudate uptake, indicated 11.6±3.6, 16.5±5.5 and 18.3±4.1 in the group of no, mild and moderate tremor, respectively, and increased as the degree of tremor advanced. The CPI in the group of moderate tremor significantly increased from that in the group of no tremor (P<0.04). However, the CPI did not correlate with the clinical stage, the degree of rigidity or the degree of bradykinesia. The FD/PET study therefore effectively demonstrated the severity of the clinical symptoms of rigidity and bradykinesia in patients with PD in correlation with a decrease in the FD uptakes in the caudate and the putamen, and it also demonstrated that the severity of tremor might have a different mechanism from that of such other symptoms as rigidity and bradykinesia.

UR - http://www.scopus.com/inward/record.url?scp=0029670370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029670370&partnerID=8YFLogxK

U2 - 10.1016/0022-510X(95)00316-T

DO - 10.1016/0022-510X(95)00316-T

M3 - Article

C2 - 8815166

AN - SCOPUS:0029670370

VL - 136

SP - 169

EP - 173

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -